After 5 years of declines in the number of new drug shortages in the U.S., they jumped to 39 last year from 26 in the two preceding years. And while that is a far cry from the peak of more
read moreHome secretary Sajid Javid has announced a review of medicinal cannabis in the UK, in response to growing pressure to allow use of cannabis oil to help control seizures in children with severe forms of epilepsy. More: UK announces review
read morePancreatic Cancer UK is calling for greater investment in research funding for pancreatic cancer as new data reveals that just three percent of patients with the most common form will survive beyond five years. More: Pancreatic cancer survival much lower
read moreNovo Nordisk and Kallyope are joining forces to discover novel peptide therapeutics for obesity and diabetes. More: Novo, Kallyope link to develop obesity, diabetes therapies Source: News
read moreEuropean regulators have awarded Amgen’s Blincyto full approval for Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the blood and bone marrow thought to affect around 900 patients a year in
read moreUS regulators have approved new evidence showing that Novartis’ Cosentyx significantly slows progression of joint structural damage in patients with active psoriatic arthritis (PsA). More: US approves joint damage data for Cosentyx Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals